Impact of risk mitigation measures on oral fluoroquinolone prescribing: a multi-site population-based Canadian cohort study.

However, our finding of a continual decrease in FQ use during the within-COVID period for all three indications is not consistent with global studies about antibiotic consumption based on sales data, which revealed a decreasing trend after the implementation of population movement restrictions followed by an increasing trend after lifting these restrictions in some countries, including Canada [ 31 , 32 ].

also in 47,180 other papers